These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4709855)

  • 1. The action of toluidine blue (TB) on the evolution of mouse Ehrlich ascites carcinoma.
    Samuel I; Popa L
    Rev Roum Virol (1972); 1973; 10(1):59-65. PubMed ID: 4709855
    [No Abstract]   [Full Text] [Related]  

  • 2. The action of dyes on tumors.
    Samuel I
    Virologie; 1978; 29(3):213-8. PubMed ID: 358561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of growth of Ehrlich ascites tumors in ICR-Ha Swiss mice by isocyanates.
    Moos GE; Maguire JA; Kitchlew TZ; Swyers WA; Volk PZ; Croft JR; Quigley MJ; Fries JR; Oser NA; Anderson LJ
    Cancer Res; 1971 Jul; 31(7):937-41. PubMed ID: 5560387
    [No Abstract]   [Full Text] [Related]  

  • 4. The antitumor action of bacterial extract. I. Suppression of mouse ascites tumors by the treatments with extracts of E. coli.
    Watanabe T
    Jpn J Exp Med; 1969 Dec; 39(6):631-47. PubMed ID: 4914751
    [No Abstract]   [Full Text] [Related]  

  • 5. Chloroaceto hydroxamic acid as antitumor agent against Ehrlich ascites carcinoma in mice.
    Sur P; Bag SP; Sur B; Khanam JA
    Neoplasma; 1997; 44(3):197-201. PubMed ID: 9372863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
    Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A
    Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influencing the mitosis rate of the Ehrlich ascites carcinoma in the white mouse with serotonin].
    Seipelt H; Iwanoff S
    Z Gesamte Exp Med Einschl Exp Chir; 1965; 139(5):433-7. PubMed ID: 5859471
    [No Abstract]   [Full Text] [Related]  

  • 8. [Laser beam effect on the growth of the Ehrlich ascites tumor].
    Mester E; Sellyei M; Tota GJ
    Arch Geschwulstforsch; 1968; 32(3):201-6. PubMed ID: 5706394
    [No Abstract]   [Full Text] [Related]  

  • 9. [Primary suspended cultures of tumor cells from transplantable ascites tumors as a model for the study of antitumor compounds].
    Ivanitskii LP; Makukho LV
    Vopr Onkol; 1973 May; 19(5):67-71. PubMed ID: 4714738
    [No Abstract]   [Full Text] [Related]  

  • 10. [Influence of immunological factors on the antitumor action of 4-diphenylylglioxal in Ehrlich ascites cancer].
    Melan F; Testorelli C
    Arch Ital Patol Clin Tumori; 1969; 12(1):57-67. PubMed ID: 5396284
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of glycyrrhizin on the evolution and respiration of Ehrlich ascites tumour cells.
    Rossi T; Galatulas I; Bossa R; Tampieri A; Tartoni P; Baggio G; Ruberto AI; Castelli M
    In Vivo; 1995; 9(3):183-6. PubMed ID: 8562878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevention of Ehrlich ascites tumor using intraperitoneal colloidal 198Au. Dose vs. size of inoculum.
    Rogoff EE; Romano R; Hahn EW
    Radiology; 1975 Jan; 114(1):225-6. PubMed ID: 1208864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further evidence on migration of lymphoid cells to peritoneal injection site of an antitumor phosphomucolipid in ascites tumor-bearing mice.
    Mita A; Nakazawa M; Yamamoto T
    Jpn J Exp Med; 1974 Aug; 44(4):311-9. PubMed ID: 4610234
    [No Abstract]   [Full Text] [Related]  

  • 14. A fraction isolated from Ehrlich ascites carcinoma as an antitumor and differentiating agent against human leukemic cell ML-2.
    Sur P; Nandi N; Ghosh P; Ghosh NC
    Neoplasma; 2000; 47(2):114-7. PubMed ID: 10985477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of various new cytostatic agents on DNA reduplication and proliferation kinetics in the Ehrlich-Lettre ascites tumor model].
    Andreeff M
    Verh Dtsch Ges Inn Med; 1974; 80():1678-80. PubMed ID: 4454511
    [No Abstract]   [Full Text] [Related]  

  • 16. Magnetic resonance imaging of mouse Ehrlich carcinoma growth inhibition by thiacarpine, an analogue of cytotoxic marine alkaloid polycarpine.
    Agafonova IG; Radchenko OS; Novikov VL; Aminin DL; Stonik VA
    Magn Reson Imaging; 2008 Jul; 26(6):763-9. PubMed ID: 18467060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of various antitumor agents on intracerebrally inoculated Ehrlich ascites carcinoma in mice (author's transl)].
    Zhou JX; He GH; Tao LX; Xu B
    Zhongguo Yao Li Xue Bao; 1981 Dec; 2(4):256-61. PubMed ID: 6462026
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the presence in the thymus of 2 fractions with antagonistic activity to tumor development].
    Potop I; Juvină E; Mreană G; Boeru V
    Arch Geschwulstforsch; 1967; 30(3):190-8. PubMed ID: 5596724
    [No Abstract]   [Full Text] [Related]  

  • 19. Antimitotic activity of the methylhydrazine derivative Natulan in the ehrlich ascites carcinoma; dose-effect relationship.
    Llombart A; Mínguez FP
    Oncology; 1969; 23(3):201-8. PubMed ID: 5785067
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effects of CHIP (Pt IV) on the cytokinetics of Ehrlich ascites carcinoma cells].
    Cao J; Pan QC
    Yao Xue Xue Bao; 1987 Feb; 22(2):93-7. PubMed ID: 3618242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.